CustoMed

Transforming Surgery Excellence with 3D-printed Patient-specific Instruments at Scale

Health Tech & Life Sciences
Active
Seed Ramat Gan Founded 2023
Website ↗
Total raised
$6.0M
Last: Seed 2025-10
Stage
Seed
Founded
2023
Headcount
3
HQ
Ramat Gan
Sector
Health Tech & Life Sciences

About

CustoMed developed an automation platform equipped with AI-powered segmentation, swiftly converting CT scans into detailed 3D anatomical models. It offers surgeons an intuitive interface for precise fine-tuning of surgical plans and PSI designs, ensuring optimal customization. Hospitals benefit from an integrated case manager and a vast library of procedures and hardware, facilitating seamless case management. The result is a computer-generated PSI, optimized for immediate printing.

Powered by vast datasets from thousands of cases, its technology harnesses state-of-the-art AI algorithms to automate segmentation, planning, and design. As it process more data, the system continually evolves, ensuring each solution is at the cutting edge of surgical excellence.

Funding history · 1 round · $6.0M total

2025-10
Seed $6.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesAssistive Devices
Technologies
Materials & SubstancesImplantsArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

surgerysurgical-instruments3d-designorthopedicsmedical-devices